Clinical trial
Phase II Trial of Palliative Radiofrequency Ablation in Metastatic Renal Cell Carcinoma Patients With Small Primary Tumor
NCT00891475 is registered in ClinicalTrials.gov with Kidney Cancer Research Bureau as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Phase II Trial of Palliative Radiofrequency Ablation in Metastatic Renal Cell Carcinoma Patients With Small Primary Tumor
- Lead sponsor
- Kidney Cancer Research Bureau
- Phase
- Phase 1/2
- Overall status
- Completed
- Start date
- May 31, 2008
- Completion date
- January 31, 2011
- Enrollment
- 114 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.